Insiders · Profile

Scanlan Sean F.

Chief Innovation Officer at TREACE MEDICAL CONCEPTS. Filing since 10 Nov 2021. CIK 0001856371

Company
Date
Role
Action
Shares
Amount
Of holding
17 Mar 2025
Chief Innovation Officer
Sold on a plan
50,000
$398.46K
12.1%
16 May 2023
Chief Innovation Officer
Sold at will
25,000
$635.98K
43.6%
9 Mar 2023
Chief Innovation Officer
Sold, plan not stated
505
$12.33K
5.1%
15 Feb 2023
Chief Innovation Officer
Sold, plan not stated
25,000
$542.24K
71.5%
12 Jan 2023
Chief Innovation Officer
Sold, plan not stated
25,000
$639.31K
71.5%
14 Nov 2022
SVP, Marketing
Sold, plan not stated
25,000
$606.68K
71.5%
2 Mar 2022
SVP, Marketing
Sold, plan not stated
25,000
$520.55K
100%
9 Feb 2022
SVP, Marketing
Sold, plan not stated
3,873
$78.08K
100%
8 Feb 2022
SVP, Marketing
Sold, plan not stated
21,127
$422.89K
100%
11 Jan 2022
SVP, Marketing
Sold, plan not stated
8,838
$177.85K
100%
10 Jan 2022
SVP, Marketing
Sold, plan not stated
38,862
$783.53K
100%
5 Jan 2022
SVP, Marketing
Sold, plan not stated
800
$16.02K
100%
4 Jan 2022
SVP, Marketing
Sold, plan not stated
500
$10.00K
100%
3 Jan 2022
SVP, Marketing
Sold, plan not stated
1,000
$20.02K
100%
10 Nov 2021
SVP, Marketing
Sold, plan not stated
25,000
$538.43K
100%
15 decisions on file.